Amyloidosis Research Consortium
Clinical Resources App
Client: Amyloidosis Research Consortium
Amyloidosis Diagnosis and Treatment App for healthcare professionals
A rare and challenging set of diseases including light chain (AL – kappa / lambda), transthyretin (hereditary, ATTR), secondary (AA) and wild-type (formerly called senile systemic), this app provides clinically relevant information that offers healthcare professionals a brief yet practical disease overview and interactive tools which can lead to earlier diagnosis and therapeutic intervention.
The content has been developed by Borm Bruckmeier Publishing in collaboration with the Amyloidosis Research Consortium and is intended for practicing physicians, resident physicians and other healthcare professionals involved in the diagnosis and treatment of patients with amyloidosis.